These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 1967930

  • 1. HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.
    Bacus SS, Bacus JW, Slamon DJ, Press MF.
    Arch Pathol Lab Med; 1990 Feb; 114(2):164-9. PubMed ID: 1967930
    [Abstract] [Full Text] [Related]

  • 2. Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.
    Baak JP, Chin D, van Diest PJ, Ortiz R, Matze-Cok P, Bacus SS.
    Lab Invest; 1991 Feb; 64(2):215-23. PubMed ID: 1671789
    [Abstract] [Full Text] [Related]

  • 3. HER-2/neu oncogene expression and proliferation in breast cancers.
    Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW.
    Am J Pathol; 1990 Jul; 137(1):103-11. PubMed ID: 1973597
    [Abstract] [Full Text] [Related]

  • 4. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE, Pollice AA, Smith CA, Janocko LE, Sweeney L, Brown KA, Singh SG, Gu L, Yakulis R, Lucke JF.
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [Abstract] [Full Text] [Related]

  • 5. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 6. DNA ploidy, proliferation, and neu-oncogene protein overexpression in breast carcinoma.
    Lee AK, Wiley B, Loda M, Bosari S, Dugan JM, Hamilton W, Heatley GJ, Cook L, Silverman ML.
    Mod Pathol; 1992 Jan 15; 5(1):61-7. PubMed ID: 1347424
    [Abstract] [Full Text] [Related]

  • 7. Quantitation of HER-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: a study comparing fresh and paraffin-embedded material.
    van Diest PJ, Baak JP, Chin D, Theeuwes JW, Bacus SS.
    Anal Cell Pathol; 1991 Jul 15; 3(4):195-202. PubMed ID: 1679345
    [Abstract] [Full Text] [Related]

  • 8. Her-2/neu oncogene expression in Puerto Rican females with breast cancer.
    Peredo R, Sastre G, Serrano J, Hunter Mellado R.
    Cell Mol Biol (Noisy-le-grand); 2001 Sep 15; 47(6):1025-32. PubMed ID: 11785652
    [Abstract] [Full Text] [Related]

  • 9. Expression of HER-2/neu oncoprotein in human breast cancer: a comparison of immunohistochemical and western blot techniques.
    Molina R, Ciocca DR, Tandon AK, Allred DC, Clark GM, Chamness GC, Gullick WJ, McGuire WL.
    Anticancer Res; 1992 Sep 15; 12(6B):1965-71. PubMed ID: 1363511
    [Abstract] [Full Text] [Related]

  • 10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL.
    APMIS Suppl; 2003 Sep 15; (108):1-67. PubMed ID: 12874968
    [Abstract] [Full Text] [Related]

  • 11. [Her-2/neu, Ki-67 expression and ploidy in breast carcinoma].
    Lukashina MI, Glukhova EI, Zhukova LG, Ermilova VD, Bogatyrev VN, Baryshnikov AIu.
    Arkh Patol; 2003 Sep 15; 65(5):25-9. PubMed ID: 14664144
    [Abstract] [Full Text] [Related]

  • 12. Her2/neu analysis in formalin-fixed, paraffin-embedded breast carcinomas: comparison of immunohistochemistry and multiparameter DNA flow cytometry.
    Leers MP, Hoop JG, Nap M.
    Anticancer Res; 2003 Sep 15; 23(2A):999-1006. PubMed ID: 12820338
    [Abstract] [Full Text] [Related]

  • 13. Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.
    Press MF, Hung G, Godolphin W, Slamon DJ.
    Cancer Res; 1994 May 15; 54(10):2771-7. PubMed ID: 7909495
    [Abstract] [Full Text] [Related]

  • 14. HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach.
    Ridolfi RL, Jamehdor MR, Arber JM.
    Mod Pathol; 2000 Aug 15; 13(8):866-73. PubMed ID: 10955453
    [Abstract] [Full Text] [Related]

  • 15. HER-2/neu oncogene expression, DNA ploidy and proliferation index in breast cancer.
    Bacus SS, Chin DM, Stern RK, Ortiz R, Ruby SG, Weinberg DS.
    Anal Quant Cytol Histol; 1992 Dec 15; 14(6):433-45. PubMed ID: 1363346
    [Abstract] [Full Text] [Related]

  • 16. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH, Tai LK, Wong LL, Sethi SK, Koay ES.
    Proteomics; 2005 May 15; 5(7):1797-805. PubMed ID: 15825149
    [Abstract] [Full Text] [Related]

  • 17. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR, Abd-Elwahed SR, Abdulwahed AR.
    Cell Biol Int; 2008 Jun 15; 32(6):698-707. PubMed ID: 18296077
    [Abstract] [Full Text] [Related]

  • 18. Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.
    Heintz NH, Leslie KO, Rogers LA, Howard PL.
    Arch Pathol Lab Med; 1990 Feb 15; 114(2):160-3. PubMed ID: 1967929
    [Abstract] [Full Text] [Related]

  • 19. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA, Pollice AA, Gu LP, Brown KA, Singh SG, Janocko LE, Johnson R, Julian T, Hyams D, Wolmark N, Sweeney L, Silverman JF, Shackney SE.
    Clin Cancer Res; 2000 Jan 15; 6(1):112-26. PubMed ID: 10656439
    [Abstract] [Full Text] [Related]

  • 20. Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.
    Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB, Slamon DJ.
    Oncogene; 1994 Jul 15; 9(7):1829-38. PubMed ID: 7911565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.